Filip De Keyser

Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

Lenny van Bon, Alsya J. Affandi, Jasper Broen et al. · New England Journal of Medicine · 2013 · 454 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

Timothy R. D. J. Radstake, Olga Y. Gorlova, Blanca Rueda‐Medina et al. · Nature Genetics · 2010 · 403 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Randomized double‐blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) versus placebo in active spondylarthropathy

Filip Van den Bosch, Elli Kruithof, Dominique Baeten et al. · Arthritis & Rheumatism · 2002 · 355 citations

Life Sciences, Immunology, Pharmacotherapy +13

Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor α (infliximab) in spondyloarthropathy: an open pilot study

Filip Van den Bosch, Elli Kruithof, Dominique Baeten et al. · Annals of the Rheumatic Diseases · 2000 · 292 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

The C-terminal RG Dipeptide Repeats of the Spliceosomal Sm Proteins D1 and D3 Contain Symmetrical Dimethylarginines, Which Form a Major B-cell Epitope for Anti-Sm Autoantibodies

Hero Brahms, Jos Raymackers, Ann Union et al. · Journal of Biological Chemistry · 2000 · 287 citations · Full text

Life Sciences, Immunology, Molecular Biology +17